Hansa Biopharma.
company in Lund, Sweden
- Reports this week
- 0
- Active events
- 0
- Connections
- 12
What's happening
One to three months ago
-
Hansa Biopharma is seeking approval for its drug Idefirix in various markets, with SERB handling commercialization in EU member states.Some support3 reports1 development inside
-
Hansa Biopharma received its first commercial patient for the drug in Australia.Some support2 reports
-
Hansa Biopharma submitted an application for full marketing authorization to the European Medicines Agency.Some support3 reports1 development inside
Gone quiet
No new reports in 90+ daysNo events began in the chosen period. Widen it, or reset.
Around Hansa Biopharma this week
News at the entities that move Hansa Biopharma most-
Iceland StructuralFrance and Canada are politically teaming up, with the French President visiting territory related to the northern hemisphere.Moves Hansa Biopharma
-
European Commission StructuralA European Commission summit focused on strategic cooperation, minerals, and pivoting away from the United States toward the EU.Moves Hansa Biopharma
-
European Medicines Agency StructuralBoth the FDA and the European Medicines Agency are evaluating NervGen's lead therapeutic candidate.Moves Hansa Biopharma
-
Liechtenstein StructuralLiechtenstein's involvement in the UN structure, including representation in the General Assembly and membership on the Advisory Board, is detailed.Moves Hansa Biopharma
-
Boston Shared contextThe Federal Aviation Administration is managing air traffic operations at Boston Logan Airport.Moves Hansa Biopharma
-
Lisbon Shared contextMayor Pete Wilson is managing the pool repair efforts in Lisbon.Moves Hansa Biopharma
Connections
The 9 strongest of 12, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
Iceland Structural
Hansa Biopharma was granted an exclusive license by Iceland for the commercialization of its product.
-
European Commission Structural
Hansa Biopharma's product, Idefirix, is currently under conditional authorization by the European Commission.
-
Liechtenstein Structural
Hansa Biopharma holds an exclusive license for commercialization within Liechtenstein.
-
European Medicines Agency Structural
Hansa Biopharma relies on the European Medicines Agency for the review and market approval of its drug candidates.
-
Uppsala University Structural
Uppsala University serves as the coordinating investigator for the clinical trials involving Hansa Biopharma.
-
Empire State Realty Trust Transactional
Hansa Biopharma secured leased premises within the Empire State Realty Trust building.
-
Lisbon Shared context
Hansa Biopharma was present in Lisbon for a specific event.
-
Boston Shared context
Hansa Biopharma operates within the context of Boston, announcing key clinical trial results at industry conferences.
Show all 9 connections
-
Lund Shared context
Hansa Biopharma is based in the city of Lund.